Vivli board members interviewed with researchers who submitted data requests using the Vivli platform to discuss the importance of their findings, but also the value of clinical trials and data sharing as a whole. A compilation of these videos can be found below:
Management of rheumatoid arthritis — A conversation with José António P. Da Silva and Dr. Ricardo J.O. Ferreira
Vivli Board Member Dr. Murray Stewart connected with researchers Prof. José António P. Da Silva and Dr. Ricardo J.O. Ferreira from the University of Coimbra to discuss the value of clinical trials, data sharing and specifically what we’ve learned about advances in rheumatology.
Dr. Ferreira and Prof. Da Silva used the Vivli platform to request data and recently published, “Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients,” in the Annals of the Rheumatic Diseases.
Watch the entire conversation:
Advancing the treatment of Crohn’s disease through data sharing— An interview with Dr. Neeraj Narula
Vivli co-founder and UCSF professor Dr. Ida Sim interviewed Dr. Neeraj Narula from McMaster University to discuss the value of clinical trials, data sharing, and what his team learned about advances in the treatment of Crohn’s disease.
Dr. Narula used the Vivli platform to request data for a number of research questions and recently published, “Predicting endoscopic remission in Crohn’s disease by the modified multiplier SES-CD (MM-SES-CD),” in Gut.
Watch the entire conversation:
Breast cancer research and data sharing – an interview with Dr. Ashley Hopkins
Vivli board member and Duke University Professor, Eric Perakslis, met with Dr. Ashley Hopkins of Flinders University to discuss the importance of his team’s research to help provide information to breast cancer patients and their doctors as to how they may react to certain medications.
Dr. Hopkins has used the Vivli platform to request data for research questions and recently published “Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib,” in Elsevier.
You can watch the entire conversation: